soul trial oral semaglutide cardiovascular outcomes results 2024 2025 nejm 🔴Cardiovascular with by severity of chronic kidney disease in type 2 diabetes: the FLOW trial⤵️ 🔹Semaglutide significantly reduced the risk of CV death/MI/stroke regardless of baseline CKD severity in participants Semaglutide and Cardiovascular Outcomes in

Since I started [tirzepatide] I began spotting monthly

Ozempic is the most popular brand-name semaglutide medication, available as an injectable (subcutaneous) formulation, to improve glycemic control in adults with type 2 diabetes, reduce the risk of cardiovascular events (heart attack, heart failure, and stroke), and prevent worsening kidney disease or kidney failure

Weight loss plateaus on semaglutide are normal and expected

Common side effects may include gastrointestinal symptoms such as nausea, vomiting, or abdominal discomfort

He isnt trying to become a bodybuilder

I need to find out does Blue Cross cover Ozempic